Evidence records
Unicycive Therapeutics, Inc. — Wikidata Q139379676 evidence
Unicycive Therapeutics, Inc. — Wikidata Q139379676; Unicycive Theraputics (Nasdaq: UNCY) is a clinical-stage biotechnology company focused on developing kidney medications; source revision 2482115829, modified 2026-04-16T10:40:47Z.
Evidence records
The details below reflect the retained source records. Follow the references to check their context; missing information is not filled in.
Source description
Unicycive Theraputics (Nasdaq: UNCY) is a clinical-stage biotechnology company focused on developing kidney medications
Sourcewww.wikidata.orgSource-listed website
unicycive.com — https://unicycive.com/
Sourcewww.wikidata.orgWikidata item
Wikidata Q139379676
Sourcewww.wikidata.orgSource revision
2482115829, modified 2026-04-16T10:40:47Z
Sourcewww.wikidata.org
Continue exploring
About these subjects
Related source records
Data & record details
Download the same cited information as JSON. The revision identifiers below distinguish changes to the facts from changes to the subjects included.
Download this recordapplication/json
- Surface ID
- urn:readyscan:corpus:evidence:unicycive-therapeutics-inc-q139379676
- Material fingerprint
- fnv1a64:2ddfd308f3b97a5d
- Membership fingerprint
- fnv1a64:9d4a9847f01ae20f
- Published
- 2026-07-29
- Modified
- 2026-07-29